Press Releases

Top - picture

LifeBond announces LifeMesh™ Self-Fixating Hernia Mesh Platform

Embedded adhesive, activated by tissue contact, is biomaterial technology breakthrough

May 15, 2014

Tel Aviv, Israel – LifeBond Ltd., a leading developer of absorbable biosurgical products for tissue repair, announced today its new self fixating hernia mesh platform, LifeMesh™, which will be presented at the upcoming MIXiii Biomed Conference, to be held at the Israel Convention Center in Tel Aviv on May 20-22. LifeMesh™ is being developed to provide strong, atraumatic fixation of prosthetic mesh for reinforcement of tissue during surgical repair of abdominal wall defects. The self-fixating surgical mesh is being developed to simplify hernia repair and reduce the complications associated with penetrative mesh fixation using tacks or sutures.

LifeMesh™ mesh fixation has the potential to be implemented in both inguinal and ventral hernia repairs, either in laparoscopic or open approach. There are approximately 1M such procedures every year, 850k Inguinal and 150K ventral, in the US alone¹. The embedded adhesive production process provides the technology to transform nearly any commercial mesh into a self-fixating mesh, thus facilitating great clinical impact across a range of hernia types.

“The successful expansion into a second, non-dependent product platform is a great achievement for our company ” said Gideon Sturlesi, CEO of LifeBond. ” Following clinical deployment of our first product, LifeSeal™ Surgical Sealant, LifeBond is now poised to rapidly realize additional products in our next-generation surgical toolbox pipeline.”

About LifeBond Ltd.

LifeBond is a leading developer and manufacturer of medical device products in the rapidly growing field of biosurgical tissue repair. LifeSealTM Surgical Sealant is designed to provide surgeons with a solution to provide staple-line reinforcement in bariatric and colorectal operations. LifeMesh™ Self-Fixating Mesh is designed to deliver secure mesh fixation without tacks or sutures. The Company’s other products in development include tissue adhesives and absorbable hemostats. LifeBond’s products are based on its proprietary platform technology that mimics the body’s natural wound healing processes. LifeSeal™, LifeMesh™ and other LifeBond™ products are investigational and have not yet been approved for sale in the US or in any other market. For more information, please contact us at:
Tel: +972-4-637-3979

Certain statements made throughout this press release that are not historical facts contain forward-looking statements regarding the Company’s future plans, objectives and expected performance. Any such forward-looking statements are based on assumptions that the Company believes are reasonable, but are subject to a wide range of risks and uncertainties and, therefore, there can be no assurance that actual results may not differ materially from those expressed or implied by such forward-looking statements.



1. Global Data, Hernia Repair-Global analysis and market forecasts, GDME0176MAR, JULY 2013